In addition to VCAM-1, validation of the overexpression of ECM-1 and LUM in RA and ApoC-II, ApoC-III and complement protein C5 in SpAs could provide newer dimensions to biomarker discovery for rheumatological diseases. Here, ECM1 is linked to rheumatoid arthritis.